Dementia Reversed in Mice, Humans Next?

Researchers have found a way to fully restore function in the brains of mice, and just received $10 million to test the method on humans.

Professor Jugen Gotz / Image: Gotz
Professor Jugen Gotz / Image: Gotz

A recent ABC article discussed an unexpected breakthrough in the treatment of dementia. A team of scientists at the Queensland Brain Institute was able to fully restore function in the brains of mice by blasting away the “toxic plaque” from their brains. The method is non-invasive, non-toxic, and consists of injecting “micro bubbles” into the brain followed by an ultrasound.

The team received $10 million in federal funding, which will allow them to test the method on up to 10 patients in Brisbane with early-onset dementia. “The goal, long term, is to come up with an affordable, portable device, which would help the millions of Alzheimer’s patients in our country and worldwide,” said Professor Jugen Gotz.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report